Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-01

Clinical Trial Update: A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) [NA]

View source ↗

Summary

Clinical trial update indicates that a prospective open-label dose-ranging study of pre-TURBT intravesical mitomycin C mixed with TC-3 Gel for non-muscle invasi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitomycin-C (mitomycin C)
  • TC-3 Gel (TC-3 Gel)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Non Muscle Invasive Bladder Cancer | NA | Status: WITHDRAWN